Solid Biosciences, Inc. (SLDB)
6.87
-0.05
(-0.72%)
USD |
NASDAQ |
Oct 07, 13:50
Solid Biosciences EPS Diluted (Quarterly) : -0.3814 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3814 |
| March 31, 2026 | -0.5167 |
| December 31, 2025 | -0.5256 |
| September 30, 2025 | -0.4848 |
| June 30, 2025 | -0.4194 |
| March 31, 2025 | -0.5921 |
| December 31, 2024 | -0.9974 |
| September 30, 2024 | -0.7896 |
| June 30, 2024 | -0.6125 |
| March 31, 2024 | -0.637 |
| December 31, 2023 | -0.9975 |
| September 30, 2023 | -1.046 |
| June 30, 2023 | -1.252 |
| March 31, 2023 | -1.537 |
| December 31, 2022 | -0.7747 |
| September 30, 2022 | -2.710 |
| June 30, 2022 | -3.335 |
| March 31, 2022 | -3.374 |
| December 31, 2021 | -2.530 |
| September 30, 2021 | -2.402 |
| Date | Value |
|---|---|
| June 30, 2021 | -2.497 |
| March 31, 2021 | -2.840 |
| December 31, 2020 | -4.659 |
| September 30, 2020 | -6.599 |
| June 30, 2020 | -5.913 |
| March 31, 2020 | -8.332 |
| December 31, 2019 | -10.39 |
| September 30, 2019 | -10.10 |
| June 30, 2019 | -11.42 |
| March 31, 2019 | -12.76 |
| December 31, 2018 | -9.28 |
| September 30, 2018 | -8.260 |
| June 30, 2018 | -7.829 |
| March 31, 2018 | -8.113 |
| December 31, 2017 | -6.363 |
| September 30, 2017 | -5.932 |
| June 30, 2017 | -4.968 |
| March 31, 2017 | -6.632 |
| December 31, 2016 | -3.490 |
| March 31, 2016 | -1.206 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
| Curis, Inc. | -4.017 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.80M |
| Total Expenses (Quarterly) | 54.80M |
| Enterprise Value | 369.31M |
| Earnings Yield | -27.78% |
| Normalized Earnings Yield | -27.19 |